Table 2. Expression of sst 1, 2 and 5 in proliferating and quiescent HUVECs, including relative expression of sst 2 and 5.
|
Receptor
|
||||||||
|---|---|---|---|---|---|---|---|---|
|
SSTR 1
|
SSTR 2
|
SSTR 3
|
SSTR 5
|
|||||
| Patient | P | Q | P | Q | P | Q | P | Q |
| 1 | − | + | + | − | − | + | + | − |
| 2 | + | + | + | − | − | − | + | − |
| 3 | + | + | + | − | − | − | − | − |
| 4 | + | + | + | − | − | − | − | − |
| 5 | + | + | + | − | − | − | + | − |
| 6 | + | − | − | − | − | − | − | − |
| 7 | − | − | + | − | + | − | + | − |
| 8 | − | + | − | − | − | − | + | − |
| 9 | − | − | 100±43.0% | 12.2±8.5% | − | − | 100±10.7% | 1.1±1.4% |
P=proliferative; Q=quiescent; HUVEC=human umbilical vein endothelial cell; SSTR=somatostatin receptor.
Experiments were performed for six replicates on each of the cultures derived from the nine patients.
Relative sst gene expression is displayed as a percentage of the corresponding proliferative cells. Each quantified value is expressed as mean±s.d.